The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry.
Published February 12, 2014 · Recall initiated: April 15, 2013
Summary
FDA records drug Class II recall D-1066-2014, published February 12, 2014 and initiated April 15, 2013. Recalling firm: Apothecure, Inc; Status: Terminated; Lot: All Lots. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
What to do
Voluntary: Firm initiated · Press Release
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Apothecure, Inc
- Distributor
- Nationwide
- Lot
- All Lots
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDANamenda XR (memantine HCl), sample pack, 28 mg, extended release capsules, packaged in 5-count sample packs,February 12, 2014
- FDAHEALTH & BEYOND DR. LARRY'S Tranquility DIETARY SUPPLEMENT 30 Capsules Manufactured for: Health & Beyond 7050February 12, 2014
- FDANamenda XR (memantine HCl), titration pack (7 mg, 14 mg, 21 mg and 28 mg) extended release capsules, packagedFebruary 12, 2014
- FDAOfloxacin Ophthalmic Solution, USP 0.3%, 5mL, (NDC 16571-130-50). The products are packaged in Low DensityFebruary 12, 2014
- FDANamenda XR (memantine HCl), 7 mg extended release capsules, 30-count bottle, Rx only, Forest PharmaceuticalsFebruary 12, 2014
- FDAOfloxacin Ophthalmic Solution, USP 0.3%, 10mL, (NDC 16571-130-11). The products are packaged in Low DensityFebruary 12, 2014
Questions about this recall
Was The firm is recalling all lots of sterile products compounded by the pharmacy that are within expiry. recalled?
Yes. FDA published recall D-1066-2014 on February 12, 2014. Reported hazard: Lack of Assurance of Sterility: The recall is being initiated due to the lack of sterility assurance and concerns associated with the quality control processes identified during an FDA inspection.
What should I do if I have this product?
Voluntary: Firm initiated · Press Release